We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-1.52%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$117M
AUM Growth
-$906K
Cap. Flow
+$1.73M
Cap. Flow %
1.48%
Top 10 Hldgs %
19.47%
Holding
135
New
4
Increased
57
Reduced
47
Closed
11

Top Buys

Rank Stock Value
1
BCE icon
BCE
BCE
+$1.28M
2
GSK icon
GSK
GSK
+$780K
3
BAX icon
Baxter International
BAX
+$763K
4
BNS icon
Scotiabank
BNS
+$598K
5
WBA
Walgreens Boots Alliance
WBA
+$577K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.51%
2 Healthcare 13.24%
3 Financials 11.97%
4 Energy 9.09%
5 Technology 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
26
Coca-Cola
KO
$383B
$1.35M 1.15%
31,546
+156
+0.5% +$6.45K
LO
27
DELISTED
LORILLARD INC COM STK
LO
$1.34M 1.15%
22,450
+3,450
+18% +$209K
AHL
28
DELISTED
ASPEN Insurance Holding Limited
AHL
$1.3M 1.11%
30,491
+3,950
+15% +$168K
IBM icon
29
IBM
IBM
$213B
$1.3M 1.11%
7,179
+51
+0.7% +$9.29K
PBCT
30
DELISTED
People's United Financial Inc
PBCT
$1.26M 1.08%
87,011
+17
+0% +$252
MMM icon
31
3M
MMM
$91.8B
$1.26M 1.08%
10,618
-417
-4% -$50.1K
XOM icon
32
ExxonMobil
XOM
$650B
$1.24M 1.06%
13,197
-172
-1% -$17.1K
LNCE
33
DELISTED
Snyders-Lance, Inc.
LNCE
$1.24M 1.06%
46,825
+3,450
+8% +$92.7K
TEVA icon
34
Teva Pharmaceuticals
TEVA
$40.4B
$1.24M 1.06%
22,984
-1,125
-5% -$59.6K
KRFT
35
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$1.23M 1.05%
21,783
+750
+4% +$43.4K
F icon
36
Ford
F
$60.9B
$1.23M 1.05%
82,927
-62
-0.1% -$1.06K
BCE icon
37
BCE
BCE
$20.8B
$1.22M 1.05%
+28,600
New +$1.28M
LYB icon
38
LyondellBasell Industries
LYB
$19.5B
$1.21M 1.03%
11,100
-600
-5% -$64.9K
BSV icon
39
Vanguard Short-Term Bond ETF
BSV
$44.7B
$1.2M 1.03%
15,030
-116
-0.8% -$9.3K
VTRS icon
40
Viatris
VTRS
$20.8B
$1.2M 1.02%
26,281
-150
-0.6% -$7.29K
EMR icon
41
Emerson Electric
EMR
$81.6B
$1.18M 1.01%
18,912
+2,640
+16% +$171K
FFBC icon
42
First Financial Bancorp
FFBC
$3.55B
$1.18M 1.01%
74,767
+4,006
+6% +$66.5K
DD icon
43
DuPont de Nemours
DD
$18.6B
$1.14M 0.97%
8,544
+2
+0% +$267
DD
44
DELISTED
Du Pont De Nemours E I
DD
$1.12M 0.96%
16,485
-316
-2% -$19.9K
EDE
45
DELISTED
Empire District Electric
EDE
$1.11M 0.95%
45,964
-750
-2% -$18.8K
DGX icon
46
Quest Diagnostics
DGX
$26B
$1.11M 0.95%
18,275
+1,550
+9% +$95.5K
CFN
47
DELISTED
CAREFUSION CORPORATION
CFN
$1.1M 0.94%
24,353
TTE icon
48
TotalEnergies
TTE
$193B
$1.06M 0.91%
16,525
-100
-0.6% -$6.63K
CAT icon
49
Caterpillar
CAT
$361B
$1.03M 0.88%
10,409
-434
-4% -$46K
KSU
50
DELISTED
Kansas City Southern
KSU
$1.02M 0.87%
8,388
-199
-2% -$22.7K

Similar funds

Kavar Capital Partners Group's Q3 2014 Portfolio in Review

As of Q3 2014, Kavar Capital Partners Group held 135 positions worth $117M, down 0.77% from $118M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Kavar Capital Partners Group's Q3 2014 filing shows 4 new, 57 increased, 47 reduced and 11 closed positions. Its largest new stake was BCE: 28,600 shares worth $1.22M. The largest sale was Seadrill Limited Common Stock, an estimated $1.08M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Kavar Capital Partners Group's largest Q3 2014 buy was BCE: 28,600 shares worth $1.22M.
  • Kavar Capital Partners Group added most to GSK in Q3 2014, an estimated $780K increase.
  • Kavar Capital Partners Group's biggest Q3 2014 reduction was Kinder Morgan, cutting an estimated $271K.
  • Kavar Capital Partners Group fully exited Seadrill Limited Common Stock in Q3 2014, selling an estimated $1.08M.
  • Kavar Capital Partners Group's ten largest holdings make up 19% of its $117M portfolio in Q3 2014.
  • Kavar Capital Partners Group opened 4 new positions and closed 11 in Q3 2014.
  • Kavar Capital Partners Group's portfolio value fell 0.77% quarter-over-quarter to $117M.

Based on Kavar Capital Partners Group's 13F filing for Q3 2014, filed 25 Jan 2019.